Pretransplantation mogamulizumab for ATLL raises risk of GVHDAugust 23, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Metabolic tumor volume predicts outcome in follicular lymphomaAugust 22, 2016Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Cancer trends shifting in HIV-positive patientsAugust 17, 2016Lung CancerLymphoma & Plasma Cell Disorders
HIV-related lymphoma rate remains sky-high despite ARTAugust 13, 2016Lymphoma & Plasma Cell Disorders
VTE risk appears to vary over time in patients with multiple myelomaAugust 12, 2016Lymphoma & Plasma Cell Disorders
Quality of life measures comparable for panobinostat or placebo in combination with bortezomib and dexamethasoneAugust 11, 2016Lymphoma & Plasma Cell Disorders
Changes in HIV-related cancers reflect changes in HIV patient careAugust 10, 2016Sarcoma & GISTLymphoma & Plasma Cell Disorders
Triptorelin doesn’t prevent ovarian failure in young women treated for lymphomaJuly 28, 2016Gynecologic CancerLymphoma & Plasma Cell DisordersPatient & Survivor Care
Ipilimumab may restore antitumor immunity after relapse from HSCTJuly 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Lack of hematology-specific measures not barrier to quality end of life careJuly 11, 2016Patient & Survivor CarePractice ManagementLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Bendamustine-based chemotherapy induces high CR rate in relapsed HLJuly 8, 2016Lymphoma & Plasma Cell Disorders
Severe psoriasis upped lymphoma risk in large cohort studyJuly 6, 2016Lymphoma & Plasma Cell DisordersPreventive Care
